DANAZOL AND LIVER DAMAGE
letter
OA: closed
CC0
⤵ 23 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper reviews the known instances and proposed mechanisms of liver damage associated with Danazol use.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (9)
- Danazol - an inhibitor of gonadotrophin secretion via openalex
- Metabolic effects of danazol. via openalex
- Sex hormones, anabolic agents and related drugs via openalex
- The use of an impeded androgen—danazol—in the management of benign breast disorders via openalex
- W2413294661 via openalex
- W2412058654 via openalex
- W4285719527 via openalex
- W6624913505 via openalex
- W6793613985 via openalex
Cited by (23)
- Dyskeratosis Congenita Complicated by Hepatic Fibrosis With Hepatic Vein Thrombosis 2013
- Therapeutic Effect and Side Effects of Danazol in Endometriosis 2010
- Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist 2007
- Danazol induced acute icteric cholestatic hepatitis 2007
- Danazol‐induced hepatocellular carcinoma 2003
- Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study 2003
- Hepatocellular adenoma and focal nodular hyperplasia after long-term use of danazol for endometriosis: a case report 2002
- BILE DUCT HAMARTOMA OCCURRING IN ASSOCIATION WITH LONG‐TERM TREATMENT WITH DANAZOL 1997
- Ultrastructural Features of Danazol-Induced Cholestasis: A Case Study 1996
- Liver Damage after Danazol and Glucocorticoids for Chronic Idiopathic Thrombocytopenic Purpura (ITP) 1995
- Liver Damage Induced by Danazol 1994
- Resolution of danazol-induced cholestasis with S-adenosylmethionine 1993
- Changing concepts of medical treatment of endometriosis 1993
- Nafarelin for endometriosis: A large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up 1992
- Cholestatic jaundice associated with danazol therapy 1992
- Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up 1992
- Medical treatment of mild endometriosis associated with infertility 1991
- Danazol induced pancreatitis and hepatitis 1990
- Preventive effect of traditional herbal medicine, shosaiko‐to, on danazol‐induced hepatic damage 1989
- Danazol and Cholestatic Hepatitis 1986
- Fulminant hepatic failure associated with aplastic anaemia after treatment with danazol. Case report 1986
- Endometriosis 1984
- Actions of danazol in vivo on cytochrome P-450 and steroidogenic enzymes in rat testis and liver microsomal preparations 1981
Source provenance
- openalex
- last seen: 2026-05-10T11:12:59.203365+00:00
License: CC0
· commercial use OK